OHE at ISPOR Latin America: Policy Options for Formulary Development in Middle-income Countries
This post summarises OHE’s activities at this year’s ISPOR Latin America conference in Santiago, September 2015. Topics include policy options for formulary development in middle-income countries, and role of HTA in definition of health benefit plans. ISPOR 5th Latin America…
This post summarises OHE’s activities at this year’s ISPOR Latin America conference in Santiago, September 2015. Topics include policy options for formulary development in middle-income countries, and role of HTA in definition of health benefit plans.
Martina Garau from OHE attended and presented key research as part of a symposium on “Sustainable universal health coverage”. Martina’s and the other panellist Manuel Espinoza’s presentations are summarised below.
Policy options for formulary development in middle-income countries
This symposium held on Sunday 6th September combined two presentations on approaches to support middle-income countries set priorities within their healthcare systems and progress towards universal health coverage.
The first presentation by Martina Garau presented initial results of a study undertaken by OHE and the University of Washington, funded by PhRMA, which sets out possible policy approaches to managing national formularies.
Key points raised included the need for formulary decision making to embrace factors linked to the health system objectives (such as provision of financial protection against catastrophic health expenditure); and that structured approaches (including simple forms of multi-criteria decision-analysis – MCDA) should be adopted to clearly define and combine the factors to consider and explicitly establish their trade-offs.
The second presentation by Manuel Antonio Espinoza (Assistant Professor, Department of Public Health, Pontificia Universidad Católica de Chile) focused on health benefits plans and how HTA processes can help inform and facilitate health benefits plans development. Manuel Espinoza also provided insights from his experience in priority setting processes in a number of Latin America countries where systematic approaches have been applied to identify priority “health problems”.
The session was chaired by Professor Adrian Towse and sought to stimulate discussion about optimal approaches for formulary decision making, disease priority setting, and health benefit plan coverage of treatments in middle-income countries.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!